Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer

Incidences of liver cancer rising in the USA

Black women found to have denser breast tissue than white women

New data shows that generic drivers are found in benign conditions

How will genomics be applied to patient therapy in future?

Inside cancer - public lecture

Pembrolizumab showed clinical benefit in malignant pleural mesothelioma

Chk1 inhibition combined with standard dose gemcitabine may be safe and effective

Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some

BRAF 'behind the scenes' in melanoma: A scientific story of discovery

Connecting science, practice and patient outcomes: Use of BRAF inhibitors for treating metastatic melanoma in clinical practice